Foundayo has arrived with a reputation as a weight loss pill, but that is only half the story. It is also licensed in the UK to help control blood sugar in type 2 diabetes, and for a lot of people the two go hand in hand. If you are managing type 2 diabetes in Swansea and want to understand what this new once-daily tablet can and cannot do, this guide walks through it honestly.
For the full overview of the treatment, including how it works and what it costs, see our complete guide to Foundayo in Swansea. This page focuses on the diabetes side: what the trials showed, who it suits, and how it fits alongside the care you already have.
The honest headline
Foundayo is licensed for type 2 diabetes, not just weight loss. In its main diabetes trial it lowered blood sugar and body weight at the same time, with no severe hypoglycaemia. It is taken alongside the care you already have, not instead of it, and it is not a replacement for insulin.
What Foundayo Is
Foundayo is Eli Lilly’s brand name for orforglipron, a once-daily tablet from the same family of medicines as Mounjaro and Wegovy, the GLP-1 receptor agonists. The difference is the form and the chemistry: Foundayo is a non-peptide, small-molecule tablet, which means it survives stomach acid intact and can be taken at any time of day, with or without food or water. It was approved by the UK medicines regulator, the MHRA, on 10 August 2026 for both weight management and type 2 diabetes, making the UK the first country in Europe to license it.
How Foundayo Helps with Type 2 Diabetes
GLP-1 is a hormone your body already makes. Foundayo works with those natural signals in three ways that matter for blood sugar. It prompts the pancreas to release insulin when blood sugar is high, and because that effect is glucose-dependent, it eases off as your blood sugar comes down, which is one reason the risk of a hypo from Foundayo on its own is low. It slows how quickly the stomach empties, which smooths out the rise in blood sugar after meals. And it reduces appetite, which helps with the weight side of things. The result for many people is better blood sugar control and, at the same time, some weight loss.
What the Diabetes Trials Show
Foundayo’s diabetes licence is backed by a large phase 3 programme called ACHIEVE. In the main monotherapy trial, ACHIEVE-1, 559 adults with early type 2 diabetes that was not well controlled by diet and exercise took Foundayo once daily for 40 weeks. On average, it lowered HbA1c, the standard three-month measure of blood sugar, by 1.3% to 1.6% from a starting point of around 8.0%. At the highest dose, participants also lost about 7.6% of their body weight, compared with 1.7% for those on a placebo.
ACHIEVE-1 Diabetes Trial (highest dose)
Up to 1.6%
average HbA1c reduction over 40 weeks
From an average starting HbA1c of 8.0%, alongside diet and activity. Weight fell by up to about 7.6% at the highest dose versus 1.7% on placebo. Individual results vary. Source: ACHIEVE-1 trial (Eli Lilly).
The wider ACHIEVE programme, across several phase 3 trials, confirmed both the blood sugar and the weight benefits, with a safety profile in line with the injectable GLP-1 medicines and no severe hypoglycaemia reported in the monotherapy trial. As with any treatment, results vary from person to person and depend on your starting point, your dose, and the diet and activity changes you make alongside it. Your prescriber will give you a realistic picture for your own situation rather than a headline number.
The Weight and Diabetes Link
Excess weight and type 2 diabetes tend to feed into each other. Carrying extra weight makes the body less responsive to insulin, and higher blood sugar can make weight harder to shift. A treatment that improves both at once is genuinely useful, because losing weight can improve insulin sensitivity and, in turn, blood sugar control. That dual action is a big part of why Foundayo has drawn so much interest for people living with type 2 diabetes, rather than for weight alone.
Who Foundayo Is For
Foundayo is licensed for adults with type 2 diabetes whose blood sugar is not well enough controlled by diet, exercise and, where used, their current medication. It is taken alongside a healthy diet and more physical activity, not instead of them. It is not a treatment for type 1 diabetes. Whether it is right for you depends on your blood sugar levels, the other medicines you take, your weight and your wider health, which is exactly what a proper assessment is for.
Working Alongside Your Existing Diabetes Care
Type 2 diabetes is usually managed with your GP and diabetes team, including your regular reviews and checks. Foundayo does not replace any of that, and starting it privately is not a reason to step away from your NHS care. We would coordinate with your existing care rather than work around it, and we would encourage you to keep your GP informed.
Safety and Side Effects
Like other GLP-1 medicines, the most common side effects of Foundayo are gastrointestinal: nausea, diarrhoea, constipation and indigestion. These are usually most noticeable early on or after a dose increase, and tend to settle as your body adjusts. Starting on a low dose and building up slowly, under the supervision of your prescriber, is designed to keep them to a minimum.
Foundayo is not suitable for everyone, including during pregnancy and breastfeeding. Your prescriber will go through your full medical history, the benefits and the risks, so you can make an informed decision, and will explain what to watch for and when to seek help before you start.
Foundayo and the NHS
Foundayo is not currently available on the NHS for type 2 diabetes. NICE, the body that decides which treatments the NHS funds, is due to give its decision on 18 November 2026. Even a positive decision would most likely mean phased, restricted access starting sometime in 2027, which is the pattern earlier GLP-1 treatments followed. For now, if you and your prescriber decide Foundayo is right for you, the route is a private prescription, and that is what we provide at Medihub.
Why Choose Medihub
A diabetes medicine deserves a proper assessment and ongoing monitoring, not a form on a website. At Medihub you are seen in person by a named Independent Prescriber: Osama Al-Saied at Killay, GPhC number 2222112, and Carwyn Jones at Pontarddulais, both publicly verifiable on the pharmacy regulator’s register. We check your blood pressure and weight at each review, talk through how you are getting on, and coordinate with your existing diabetes care. For how to get started and current pricing, see our complete guide to Foundayo in Swansea.
Both branches offer the same service. Killay on Gower Road, SA2 7BA, serves Killay, Sketty, West Cross and the Gower peninsula. Pontarddulais on St Teilo Street, SA4 8ST, is convenient for Pontarddulais, Gorseinon, Llansamlet and Morriston, and the wider Swansea area.
Managing type 2 diabetes and want to know if Foundayo fits?
Book a consultation at our Killay or Pontarddulais branch and we will talk it through properly, alongside your existing care.
Frequently Asked Questions
Is Foundayo for diabetes or for weight loss?
Both. Foundayo is licensed in the UK for type 2 diabetes and, separately, for weight management. Many people benefit from both effects at once, but your prescriber will focus on the goal that matters most for your health.
How much can Foundayo lower my blood sugar?
In its main diabetes trial, Foundayo lowered HbA1c by 1.3% to 1.6% on average over 40 weeks, from a starting point of around 8.0%. Your own result depends on your starting level, your dose and the changes you make alongside it, so treat that as a guide rather than a promise.
Can I take Foundayo with metformin or insulin?
Often yes, but that is a decision for your prescriber, who will look at everything you take. Do not stop or change any current diabetes medicine on your own. If you take insulin or a sulfonylurea, your prescriber may adjust the doses to reduce the risk of low blood sugar.
Will Foundayo cause hypos?
On its own the risk is low, because Foundayo mainly prompts insulin when blood sugar is high. The risk of a hypo goes up if it is combined with insulin or a sulfonylurea, which is why your prescriber reviews your other medicines carefully.
Is Foundayo available on the NHS for diabetes?
Not currently. NICE is due to decide on 18 November 2026, and even a positive decision would likely mean phased, restricted access from 2027. For now it is available privately, which is what we offer at Medihub.
Can I get Foundayo for diabetes in Swansea?
Yes. Medihub Pharmacy offers Foundayo privately at both its Swansea branches, Killay and Pontarddulais, with a face-to-face assessment, ongoing monitoring, and coordination with your existing diabetes care. No GP referral is needed to book.
Foundayo brings the blood sugar and weight benefits of a GLP-1 treatment into a once-daily tablet, which is a real step forward for many people with type 2 diabetes. If you would like to know whether it is right for you, book a consultation at your nearest Swansea branch, or read our complete guide to Foundayo in Swansea for the full overview.
To be reviewed and verified by
Osama Al-Saied, Independent Prescriber
GPhC Number: 2222112 | Independent Prescriber
Medihub Pharmacy, Killay and Pontarddulais, Swansea
Verify on the GPhC register
